eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry on Qualification Process for Drug Development Tools; Availability

Draft Guidance for Industry on Qualification Process for Drug Development Tools; Availability

Document ID: FDA-2010-D-0529-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2010-26927
View Document:  View as format pdf View as format html

Details Information

Document Subtype: GDL-Guidance
Received Date: October 22 2010, at 12:00 AM Eastern Daylight Time
Start-End Page: 65495 - 65496
Page Count: 2
Comment Start Date: October 25 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: January 24 2011, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 15
Novo Nordisk Inc. - Comment
Posted: 01/18/2011     ID: FDA-2010-D-0529-0003

Jan 24,2011 11:59 PM ET
Amgen, Inc. - Comment
Posted: 01/31/2011     ID: FDA-2010-D-0529-0007

Jan 24,2011 11:59 PM ET
Bausch+Lomb - Comment
Posted: 01/31/2011     ID: FDA-2010-D-0529-0008

Jan 24,2011 11:59 PM ET
Quintiles - Comment
Posted: 01/31/2011     ID: FDA-2010-D-0529-0009

Jan 24,2011 11:59 PM ET
International Society for CNS Clinical Trials and Methodology (ISCTM) - Comment
Posted: 01/31/2011     ID: FDA-2010-D-0529-0010

Jan 24,2011 11:59 PM ET

Related Documents

Total: 0
No documents available.